Biomind Labs to Upgrade to the OTCQB Venture Market in US
Biomind Labs Inc., a leading biotechnology company that is focusing on the innovation and research on the endogenous tryptamines used for the treatment of the mental health disorders announced that, the company’s successful upgrade from the OTC Pink to the OTCQB Venture Market, a trading platform of the United States operated by the OTC Markets […]
Continue Reading